The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent form of pancreatic cancer and presents a 5-year survival rate of less than 10%. Novel therapies focusing on targeting the tumor ...